Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Igarashi, Hirotaka ^a   Maeda, Shingo ^a   Ohno, Koichi ^a   Horigome, Ayako ^b   Odamaki, Toshitaka ^b   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; METRONIDAZOLE; PREDNISOLONE; RNA 16S;

ACIDAMINOCOCCACEAE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; BACTEROIDACEAE; BIFIDOBACTERIACEAE; CLOSTRIDIACEAE; CONTROLLED STUDY; DNA EXTRACTION; DOG; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROCOCCACEAE; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FUSOBACTERIACEAE; GRAM POSITIVE BACTERIUM; HIGH THROUGHPUT SEQUENCING; LACHNOSPIRACEAE; MALE; NONHUMAN; RNA SEQUENCE; RUMINOCOCCACEAE; SEQUENCE ANALYSIS; SPECIES COMPOSITION; SPECIES DIVERSITY; STREPTOCOCCACEAE; TURICIBACTERACEAE; ANIMAL; BACTERIUM; BIODIVERSITY; CLASSIFICATION; DRUG EFFECTS; FECES; GENETICS; MICROBIOLOGY; MICROFLORA; ORAL DRUG ADMINISTRATION;

CANIS FAMILIARIS;

ADMINISTRATION, ORAL; ANIMALS; BACTERIA; BIODIVERSITY; DOGS; FECES; FEMALE; MALE; METRONIDAZOLE; MICROBIOTA; PREDNISOLONE; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA;

EID: 84907212862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107909     Document Type: Article

References (72)

1. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, et al. (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884.
2. Hooda S, Minamoto Y, Suchodolski JS, Swanson KS (2012) Current state of knowledge: the canine gastrointestinal microbiome. Anim Health Res Rev 13: 78-88.
3. Mackie RI, Sghir A, Gaskins HR (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69: 1035S-1045S.
4. Kanauchi O, Matsumoto Y, Matsumura M, Fukuoka M, Bamba T (2005) The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease. Curr Pharm Des 11: 1047-1053.
5. Sunvold GD, Fahey GC Jr, Merchen NR, Reinhart GA (1995) In vitro fermentation of selected fibrous substrates by dog and cat fecal inoculum: influence of diet composition on substrate organic matter disappearance and short-chain fatty acid production. J Anim Sci 73: 1110-1122.
6. Packey CD, Sartor RB (2009) Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22: 292-301.
7. Suchodolski JS (2011) Companion animals symposium: microbes and gastrointestinal health of dogs and cats. J Anim Sci 89: 1520-1530.
8. Marks SL, Rankin SC, Byrne BA, Weese JS (2011) Enteropathogenic bacteria in dogs and cats: diagnosis, epidemiology, treatment, and control. J Vet Intern Med 25: 1195-1208.
9. Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, et al. (2012) The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLOS ONE 7: e51907.
10. Allenspach K, House A, Smith K, McNeill FM, Hendricks A, et al. (2010) Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German shepherd dogs with chronic enteropathies. Vet Microbiol 146: 326-335.
11. Suchodolski JS, Dowd SE, Wilke V, Steiner JM, Jergens AE (2012) 16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of dogs with idiopathic inflammatory bowel disease. PLOS ONE 7: e39333.
12. Suchodolski JS, Xenoulis PG, Paddock CG, Steiner JM, Jergens AE (2010) Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease. Vet Microbiol 142: 394-400.
13. Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, et al. (2008) Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol 66: 579-589.
14. Allenspach K, Wieland B, Gröne A, Gaschen F (2007) Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 21: 700-708.
15. Craven M, Simpson JW, Ridyard AE, Chandler ML (2004) Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J Small Anim Pract 45: 336-342.
16. Jergens AE, Crandell J, Morrison JA, Deitz K, Pressel M, et al. (2010) Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial. J Vet Intern Med 24: 269-277.
17. Garćia-Sancho M, Rodŕiguez-Franco F, Sainz A, Mancho C, Rodŕiguez A (2007) Evaluation of clinical, macroscopic, and histopathologic response to treatment in nonhypoproteinemic dogs with lymphocytic-plasmacytic enteritis. J Vet Intern Med 21: 11-17.
18. Middelbos IS, Vester Boler BM, Qu A, White BA, Swanson KS, et al. (2010) Phylogenetic characterization of fecal microbial communities of dogs fed diets with or without supplemental dietary fiber using 454 pyrosequencing. PLOS ONE 5: e9768.
19. Hang I, Rinttila T, Zentek J, Kettunen A, Alaja S, et al. (2012) Effect of high contents of dietary animal-derived protein or carbohydrates on canine faecal microbiota. BMC Vet Res 8: 90.
20. Garcia-Mazcorro JF, Lanerie DJ, Dowd SE, Paddock CG, Grützner N, et al. (2011) Effect of a multi-species synbiotic formulation on fecal bacterial microbiota of healthy cats and dogs as evaluated by pyrosequencing. FEMS Microbiol Ecol 78: 542-554.
21. Beloshapka AN, Dowd SE, Suchodolski JS, Steiner JM, Duclos L, et al. (2013) Fecal microbial communities of healthy adult dogs fed raw meat-based diets with or without inulin or yeast cell wall extracts as assessed by 454 pyrosequencing. FEMS Microbiol Ecol 84: 532-541.
22. Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Wolcott RD, et al. (2009) The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol 9: 210.
23. Baldwin K, Bartges J, Buffington T, Freeman LM, Grabow M, et al. (2010) AAHA nutritional assessment guidelines for dogs and cats. J Am Anim Hosp Assoc 46: 285-296.
24. Münster M, Hörauf A, Bilzer T (2006) Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease. Berl Munch Tierarztl Wochenschr 119: 493-505.
25. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, et al. (2012) Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6: 1621-1624.
26. Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460-2461.
27. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R (2011) UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194-2200.
28. Chao A (1987) Estimating the population size for capture-recapture data with unequal catchability. Biometrics 43: 783-791.
29. Shannon CE (1948) A mathematical theory of communication. Bell Syst Tech J: 379-423 and 623-656.
30. Kerr KR, Beloshapka AN, Swanson KS (2013) 2011 and 2012 Early Careers Achievement Awards: use of genomic biology to study companion animal intestinal microbiota. J Anim Sci 91: 2504-2511.
31. Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner JM, et al. (2014) Comparison of Microbiological, Histological, and Immunomodulatory Parameters in Response to Treatment with Either Combination Therapy with Prednisone and Metronidazole or Probiotic VSL#3 Strains in Dogs with Idiopathic Inflammatory Bowel Disease. PLOS ONE 9: e94699.
32. Roe FJ (1977) Metronidazole: review of uses and toxicity. J Antimicrob Chemother 3: 205-212.
33. Upcroft P, Upcroft JA (2001) Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 14: 150-164.
34. Jergens AE (1994) Rational use of antimicrobials for gastrointestinal disease in small animals. J Am Anim Hosp Assoc 30: 123-131.
35. Borriello SP (1995) Clostridial disease of the gut. Clin Infect Dis 20: S242-S250.
36. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, et al. (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232-236.
37. Marks SL, Kather EJ (2003) Bacterial-associated diarrhea in the dog: a critical appraisal. Vet Clin North Am Small Anim Pract 33: 1029-1060.
38. Cave NJ, Marks SL, Kass PH, Melli AC, Brophy MA (2002) Evaluation of a routine diagnostic fecal panel for dogs with diarrhea. J Am Vet Med Assoc 221: 52-59.
39. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105: 16731-16736.
40. Liu C, Finegold SM, Song Y, Lawson PA (2008) Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Rumino-coccus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 58: 1896-1902.
41. Allen-Vercoe E, Strauss J, Chadee K (2011) Fusobacterium nucleatum: an emerging gut pathogen? Gut Microbes 2: 294-298.
42. Citron DM (2002) Update on the taxonomy and clinical aspects of the genus fusobacterium. Clin Infect Dis 35: S22-S27.
43. Vasquez N, Suau A, Magne F, Pochart P, Pélissier MA (2009) Differential effects of Bifidobacterium pseudolongum strain Patronus and metronidazole in the rat gut. Appl Environ Microbiol 75: 381-386.
44. Tanabe S, Kinuta Y, Saito Y (2008) Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int J Mol Med 22: 181-185.
45. Jiang T, Savaiano DA (1997) Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production. Dig Dis Sci 42: 2370-2377.
46. Vieira AT, Teixeira MM, Martins FS (2013) The Role of Probiotics and Prebiotics in Inducing Gut Immunity. Front Immunol 4: 445.
47. Chrzastowska M, Kander M, Depta A (2009) Prospects for the use of probiotic bacteria in the treatment of gastrointestinal diseases in dogs. Pol J Vet Sci 12: 279-284.
48. Gupta V, Garg R (2009) Probiotics. Indian J Med Microbiol 27: 202-209.
49. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, et al. (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307: 1959-1969.
50. Kennedy NA, Walker AW, Berry SH, Duncan SH, Farquarson FM, et al. (2014) The Impact of Different DNA Extraction Kits and Laboratories upon the Assessment of Human Gut Microbiota Composition by 16S rRNA Gene Sequencing. PLOS ONE 9: e88982.
51. Claesson MJ, Wang Q, O'Sullivan O, Greene-Diniz R, Cole JR, et al. (2010) Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res 38: e200.
52. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
53. Simpson KW, Dogan B, Rishniw M, Goldstein RE, Klaessig S, et al. (2006) Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 74: 4778-4792.
54. Abujamel T, Cadnum JL, Jury LA, Sunkesula VC, Kundrapu S, et al. (2013) Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole. PLOS ONE 8: e76269.
55. Dion YM, Richards GK, Prentis JJ, Hinchey EJ (1980) The influence of oral versus parenteral preoperative metronidazole on sepsis following colon surgery. Ann Surg 192: 221-226.
56. Nitzan O, Elias M, Chazan B, Raz R, Saliba W (2013) Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol 19: 7577-7585.
57. Kanizaj TF, Kunac N (2014) Helicobacter pylori: Future perspectives in therapy reflecting three decades of experience. World J Gastroenterol 20: 699-705.
58. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLOS Biol 6: e280.
59. Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108: 4554-4561.
60. De La Cochetière MF, Durand T, Lepage P, Bourreille A, Galmiche JP, et al. (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43: 5588-5592.
61. Relman DA (2012) The human microbiome: ecosystem resilience and health. Nutr Rev 70: S2-S9.
62. McFarland LV (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101: 812-822.
63. Willard MD, Berridge B, Braniecki A, Bouley D (1998) Possible antibiotic-associated colitis in a dog. J Am Vet Med Assoc 213: 1775-1779.
64. Ayyagari A, Agarwal J, Garg A (2003) Antibiotic associated diarrhoea: infectious causes. Indian J Med Microbiol 21: 6-11.
65. Martin SJ, Yost RJ (2011) Infectious diseases in the critically ill patients. J Pharm Pract 24: 35-43.
66. Sharma R, Sharma CL, Kapoor B (2005) Antibacterial resistance: current problems and possible solutions. Indian J Med Sci 59: 120-129.
67. Malewska K, Rychlik A, Nieradka R, Kander M (2011) Treatment of inflammatory bowel disease (IBD) in dogs and cats. Pol J Vet Sci 14: 165-171.
68. Cario E (2010) Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 16: 1583-1597.
69. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
70. Kahn CE (2005) The Merck Veterinary Manual 9th ed. NJ: Merck & Co Whitehouse Station. 2128 p.
71. Tsukamoto A, Ohno K, Maeda S, Nakashima K, Fukushima K, et al. (2012) Effect of mosapride on prednisolone-induced gastric mucosal injury and gastric-emptying disorder in dog. J Vet Med Sci 74: 1103-1108.
72. Garcia-Mazcorro JF, Dowd SE, Poulsen J, Steiner JM, Suchodolski JS (2012) Abundance and short-term temporal variability of fecal microbiota in healthy dogs. Microbiologyopen 1: 340-347.